Search Results

Return to List
Results 1–20 of 21
Sort By: Relevance | Date | Title
1.

Guidelines for Diagnostic Imaging During Pregnancy and Lactation

Committee Opinion Number 656, February 2016

(Replaces Committee Opinion Number 299, September 2004)

ABSTRACT Imaging studies are important adjuncts in the diagnostic evaluation of acute and chronic conditions However confusion about the safety of these modalities for pregnant and lactating women and their infants often results in unnecessary avoidance of useful diagnostic tests or the unnecessar...

February 2016

PDF Format
2.

Dual Therapy for Gonococcal Infections

Committee Opinion Number 645, November 2015

ABSTRACT Gonorrhea is the second most commonly reported bacterial sexually transmitted disease in the United States with an estimated 820000 new Neisseria gonorrhoeae infections occurring each year Antimicrobial resistance limits treatment success heightens the risk of complications and may facili...

November 2015

PDF Format
3.

The Apgar Score

Committee Opinion Number 644, October 2015

(Replaces Committee Opinion Number 333, May 2006)

ABSTRACT The Apgar score provides an accepted and convenient method for reporting the status of the newborn infant immediately after birth and the response to resuscitation if needed The Apgar score alone cannot be considered to be evidence of or a consequence of asphyxia does not predict individu...

October 2015

PDF Format
4.

Identification and Referral of Maternal Genetic Conditions in Pregnancy

Committee Opinion Number 643, October 2015

ABSTRACT Advances in the understanding of genetic conditions reproductive technologies and improved medical and surgical care have enabled an increasing number of women with genetic conditions to achieve a normal pregnancy outcome However management of certain genetic conditions during pregnancy i...

October 2015

PDF Format
5.

Cell-free DNA Screening for Fetal Aneuploidy

Committee Opinion Number 640, September 2015

(This Committee Opinion Replaces Committee Opinion Number 545)

ABSTRACT Noninvasive prenatal screening that uses cellfree DNA from the plasma of pregnant women offers tremendous potential as a screening method for fetal aneuploidy A number of laboratories have validated different techniques for the use of cellfree DNA as a screening test for fetal aneuploidy ...

September 2015

PDF Format
6.

First-Trimester Risk Assessment for Early-Onset Preeclampsia

Committee Opinion Number 638, September 2015

ABSTRACT Hypertensive disorders with adverse sequelae including preterm birth maternal morbidity and mortality and longterm risk of maternal cardiovascular disease complicate 510 of pregnancies Early identification of pregnant women at risk of developing earlyonset preeclampsia would theoretically...

September 2015

PDF Format
7.

Screening for Perinatal Depression

Committee Opinion Number 630, May 2015

(Replaces Committee Opinion Number 453, February 2010)

ABSTRACT Perinatal depression which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery is one of the most common medical complications during pregnancy and the postpartum period affecting one in seven women It is important to identify ...

May 2015

PDF Format
8.

Ovarian Reserve Testing

Committee Opinion Number 618, January 2015

ABSTRACT The main goal of ovarian reserve testing is to identify those individuals who are at risk of decreased or diminished ovarian reserve commonly known as DOR Although ovarian reserve testing cannot predict the end of ones reproductive years results outside the range expected for a patients a...

January 2015

PDF Format
9.

The Use of Chromosomal Microarray Analysis in Prenatal Diagnosis

Committee Opinion Number 581, December 2013

(Replaces No. 446, November 2009. Reaffirmed 2015)
(See also Practice Bulletin No. 88)

ABSTRACT Chromosomal microarray analysis is a technique that identifies chromosomal abnormalities including submicroscopic abnormalities that are too small to be detected by conventional karyotyping Like conventional fetal karyotyping prenatal chromosomal microarray analysis requires direct testin...

December 2013

PDF Format
10.

Solutions for Surgical Preparation of the Vagina

Committee Opinion Number 571, September 2013

(Reaffirmed 2015)

ABSTRACT Currently only povidoneiodine preparations are approved for vaginal surgicalsite antisepsis However there are compelling reasons to consider chlorhexidine gluconate solutions for offlabel use in surgical preparation of the vagina especially in women with allergies to iodine Although chlor...

September 2013

PDF Format
11.

Reproductive Health Care for Incarcerated Women and Adolescent Females

Committee Opinion Number 535, August 2012

ABSTRACT Increasing numbers of women and adolescent females are incarcerated each year in the United States and they represent an increasing proportion of inmates in the US correctional system Incarcerated women and adolescent females often come from disadvantaged environments and have high rates ...

August 2012

PDF Format
12.

Lead Screening During Pregnancy and Lactation

Committee Opinion Number 533, August 2012

(Reaffirmed 2016)

Abstract Prenatal lead exposure has known adverse effects on maternal health and infant outcomes across a wide range of maternal blood lead levels Adverse effects of lead exposure are being identified at lower levels of exposure than previously recognized in both children and adults In 2010 the Ce...

August 2012

PDF Format
13.

Placenta Accreta

Committee Opinion Number 529, July 2012

Reaffirmed 2015

ABSTRACT Placenta accreta is a potentially lifethreatening obstetric condition that requires a multidisciplinary approach to management The incidence of placenta accreta has increased and seems to parallel the increasing cesarean delivery rate Women at greatest risk of placenta accreta are those w...

July 2012

PDF Format
14.

Intimate Partner Violence

Committee Opinion Number 518, February 2012

ABSTRACT Intimate partner violence IPV is a significant yet preventable public health problem that affects millions of women regardless of age economic status race religion ethnicity sexual orientation or educational background Individuals who are subjected to IPV may have lifelong consequences in...

February 2012

PDF Format
15.

At-Risk Drinking and Alcohol Dependence: Obstetric and Gynecologic Implications

Committee Opinion Number 496, August 2011

(Reaffirmed 2013)

ABSTRACT Compared with men atrisk alcohol use by women has a disproportionate effect on their health and lives including reproductive function and pregnancy outcomes Obstetriciangynecologists have a key role in screening and providing brief intervention patient education and treatment referral for...

August 2011

PDF Format
16.

Update on Carrier Screening for Cystic Fibrosis

Committee Opinion Number 486, April 2011

(Reaffirmed 2014, Replaces No. 325, December 2005)

ABSTRACT In 2001 the American College of Obstetricians and Gynecologists and the American College of Medical Genetics introduced guidelines for prenatal and preconception carrier screening for cystic fibrosis The American College of Obstetricians and Gynecologists Committee on Genetics has updated...

April 2011

PDF Format
17.

Carrier Screening for Fragile X Syndrome

Committee Opinion Number 469, October 2010

(Reaffirmed 2014, Replaces No. 338, June 2006)

ABSTRACT Fragile X syndrome is the most common inherited form of mental retardation The syndrome occurs in approximately 1 in 3600 males and 1 in 40006000 females Approximately 1 in 250 females carry the premutation DNAbased molecular analysis is the preferred method of diagnosis for fragile X syn...

October 2010

PDF Format
18.

Preconception and Prenatal Carrier Screening for Genetic Diseases in Individuals of Eastern European Jewish Descent

Committee Opinion Number 442, October 2009

(Reaffirmed 2014, Replaces No. 298, August 2004)

ABSTRACT Certain autosomal recessive disease conditions are more prevalent in individuals of Eastern European Jewish Ashkenazi descent Previously the American College of Obstetricians and Gynecologists recommended that individuals of Eastern European Jewish ancestry be offered carrier screening fo...

October 2009

PDF Format
19.

Human Immunodeficiency Virus

Committee Opinion Number 389, December 2007

(Reaffirmed 2015)

ABSTRACT Because human immunodeficiency virus HIV infection often is detected through prenatal and sexually transmitted disease testing an obstetriciangynecologist may be the first health professional to provide care for a woman infected with HIV Universal testing with patient notification and rig...

December 2007

PDF Format
20.

Screening for Tay - Sachs Disease

Committee Opinion Number 318, October 2005

(Reaffirmed 2014, Replaces No. 162, November 1995)

ABSTRACT TaySachs disease TSD is a severe progressive neurologic disease that causes death in early childhood Carrier screening should be offered before pregnancy to individuals and couples at high risk including those of Ashkenazi Jewish FrenchCanadian or Cajun descent and those with a family his...

October 2005

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998